These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8738800)

  • 21. Beneficial effect of nifedipine and moxonidine on glomerulosclerosis in spontaneously hypertensive rats. A micromorphometric study.
    Irzyniec T; Mall G; Greber D; Ritz E
    Am J Hypertens; 1992 Jul; 5(7):437-43. PubMed ID: 1637515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rats with moderate renal failure show capillary deficit in heart but not skeletal muscle.
    Amann K; Neimeier KA; Schwarz U; Törnig J; Matthias S; Orth SR; Mall G; Ritz E
    Am J Kidney Dis; 1997 Sep; 30(3):382-8. PubMed ID: 9292567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of gene expression by moxonidine in rats with chronic renal failure.
    Vonend O; Apel T; Amann K; Sellin L; Stegbauer J; Ritz E; Rump LC
    Nephrol Dial Transplant; 2004 Sep; 19(9):2217-22. PubMed ID: 15266031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition.
    Grimm D; Kromer EP; Böcker W; Bruckschlegel G; Holmer SR; Riegger GA; Schunkert H
    J Hypertens; 1998 Sep; 16(9):1345-55. PubMed ID: 9746122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activity.
    Nabokov A; Amann K; Gassmann P; Schwarz U; Orth SR; Ritz E
    Nephrol Dial Transplant; 1998 Jan; 13(1):173-6. PubMed ID: 9481735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients.
    Cholley BP; Shroff SG; Sandelski J; Korcarz C; Balasia BA; Jain S; Berger DS; Murphy MB; Marcus RH; Lang RM
    Circulation; 1995 Feb; 91(4):1052-62. PubMed ID: 7850941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
    Linz W; Schölkens BA; Ganten D
    Clin Exp Hypertens A; 1989; 11(7):1325-50. PubMed ID: 2530011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nifedipine and moxonidine on cardiac structure in spontaneously hypertensive rats (SHR)--stereological studies on myocytes, capillaries, arteries, and cardiac interstitium.
    Mall G; Greber D; Gharenhbaghi H; Wiest G; Amann K; Mattfeldt T
    Basic Res Cardiol; 1991; 86 Suppl 3():33-44. PubMed ID: 1781768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes.
    Gross ML; Heiss N; Weckbach M; Hansen A; El-Shakmak A; Szabo A; Münter K; Ritz E; Amann K
    Diabetologia; 2004 Feb; 47(2):316-24. PubMed ID: 14727024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production.
    Ogawa T; Linz W; Stevenson M; Bruneau BG; Kuroski de Bold ML; Chen JH; Eid H; Schölkens BA; de Bold AJ
    Circulation; 1996 Jun; 93(11):2059-67. PubMed ID: 8640983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin-1-induced vasopressor responses in essential hypertension.
    Kaasjager KA; Koomans HA; Rabelink TJ
    Hypertension; 1997 Jul; 30(1 Pt 1):15-21. PubMed ID: 9231815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.
    Linz W; Schaper J; Wiemer G; Albus U; Schölkens BA
    Br J Pharmacol; 1992 Dec; 107(4):970-5. PubMed ID: 1334756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats.
    Koleganova N; Piecha G; Ritz E; Gross ML
    Nephrol Dial Transplant; 2009 Mar; 24(3):778-87. PubMed ID: 18829613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
    Adamczak M; Gross ML; Amann K; Ritz E
    J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoregulation of total and zonal glomerular filtration rate in spontaneously hypertensive rats during antihypertensive therapy.
    Wang X; Aukland K; Iversen BM
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):833-41. PubMed ID: 8961082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.
    Burrell LM; Gayed D; Griggs K; Patel SK; Velkoska E
    PLoS One; 2017; 12(2):e0171975. PubMed ID: 28192475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis.
    Sabino B; Lessa MA; Nascimento AR; Rodrigues CA; Henriques Md; Garzoni LR; Levy BI; Tibiriçá E
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):402-9. PubMed ID: 18427284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonhypotensive dose of beta-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure.
    Amann K; Hofstetter J; Câmpean V; Koch A; Gross ML; Veelken R; Ritz E
    Virchows Arch; 2006 Aug; 449(2):207-14. PubMed ID: 16691425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.